See also this year's filing and all EDGAR filings for this company.
PDF Report 0000849636_2017_RespireRx_Pharmaceuticals_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0000849636')"} |
Graph
Absolute values for 0000849636, RespireRx Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 195,676 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 5,167 |
| 3 | remainder_Assets | 33,004 |
| 4 | LiabilitiesCurrent | 5,727,224 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 5,295,683 |
| 9 | ResearchAndDevelopmentExpense | 3,176,207 |
| 10 | remainder_Expenses | 773,544 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 15,674 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 233,847 |
| 1 | Liabilities | 5,727,224 |
| 2 | Expenses | 9,245,434 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -5,493,377 |
| 5 | NetIncome | -9,229,760 |
| 6 | ComprehensiveNetIncome | -9,229,760 |
| 7 | BaseVar | 7,611,090 |
| 8 | EconomicCapitalRatio | -6.27 |
Edgar->Model Mapping
Feature Distribution
